Divi's Laboratories

quarterly
yearly
ParticularsJun '22Sep '22Dec '22Mar '23Jun '23
Revenue2,3431,9351,8222,0171,859
Expenses1,4911,3191,3861,5511,367
EBITDA937.00701.12522.53553.00585.00
EBIT852.00615.39435.76466.00492.00
Profit Before Tax852.00615.22435.63466.00492.00
Net Profit702.00493.60306.80321.00356.00
Financial Ratios
Earning Per Share (Diluted)26.4418.6011.5612.0913.41
Dividends Per Share0.000.000.000.000.00
Operating Profit Margin41.55%37.81%30.60%34.94%32.90%
Net Profit Margin31.13%26.62%17.97%23.47%20.02%
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.3.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ